2.2001
price down icon8.71%   -0.21
after-market アフターアワーズ: 2.20 -0.000100 -0.00%
loading
前日終値:
$2.4101
開ける:
$2.3
24時間の取引高:
1,039
Relative Volume:
0.05
時価総額:
$5.41M
収益:
$453.80K
当期純損益:
$-1.03M
株価収益率:
-3.0625
EPS:
-0.7184
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-8.33%
1か月 パフォーマンス:
-15.38%
6か月 パフォーマンス:
-18.82%
1年 パフォーマンス:
-88.44%
1日の値動き範囲:
Value
$2.2001
$2.43
1週間の範囲:
Value
$2.1859
$2.50
52週間の値動き範囲:
Value
$2.0101
$41.12

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile

Name
名前
X T L Biopharmaceuticals Ltd Adr
Name
セクター
Healthcare (1067)
Name
電話
-
Name
住所
-
Name
職員
2
Name
Twitter
@xtlbio
Name
次回の収益日
2026-04-29
Name
最新のSEC提出書
Name
XTLB's Discussions on Twitter

Compare XTLB vs VRTX, REGN, MRNA, ARGX, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
XTLB icon
XTLB
X T L Biopharmaceuticals Ltd Adr
2.2001 5.41M 453.80K -1.03M 0 -0.7184
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
526.19 133.37B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
788.04 81.13B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
198.88 79.40B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
959.49 60.03B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
204.97 43.93B 742.00K -1.37B -1.07B -7.0731

X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2015-05-08 開始されました H.C. Wainwright Buy

X T L Biopharmaceuticals Ltd Adr (XTLB) 最新ニュース

pulisher
Sep 10, 2026

XTL Biopharmaceuticals (XTLB) Trades Flat at $2.56, Sitting Midway Between Support and ResistanceLiquidity Sweep - dars.gov.et

Sep 10, 2026
pulisher
Aug 05, 2026

XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition - TipRanks

Aug 05, 2026
pulisher
Jul 25, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Revenue Breakdown – FWB:HHB0 - TradingView

Jul 25, 2026
pulisher
Jul 22, 2026

XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period - The Globe and Mail

Jul 22, 2026
pulisher
Jul 21, 2026

XTLB Stock Price, Quote & Chart - ChartMill

Jul 21, 2026
pulisher
Jul 12, 2026

Enterprise value to EBITDA forward of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Jul 12, 2026
pulisher
Jun 30, 2026

XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine - TipRanks

Jun 30, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase - TipRanks

Jun 29, 2026
pulisher
Jun 29, 2026

Wondering what's happening in today's after-hours session? - ChartMill

Jun 29, 2026
pulisher
Jun 29, 2026

XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026 - TipRanks

Jun 29, 2026
pulisher
May 29, 2026

XTL Biopharmaceuticals (XTLB) Stock Price, News & Analysis $XTLB - MarketBeat

May 29, 2026
pulisher
May 26, 2026

XTLB - Finviz

May 26, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report - TipRanks

May 22, 2026
pulisher
May 22, 2026

XTL Biopharmaceuticals faces additional Nasdaq delisting risk - Investing.com

May 22, 2026
pulisher
May 20, 2026

Eastern International Ltd. expands board, appoints two new directors - Investing.com

May 20, 2026
pulisher
May 16, 2026

XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise - The Globe and Mail

May 16, 2026
pulisher
May 15, 2026

SMX increases authorized shares for incentive plan and grants restricted stock units - Investing.com

May 15, 2026
pulisher
May 07, 2026

XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal - TipRanks

May 07, 2026
pulisher
Apr 30, 2026

XTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation - TipRanks

Apr 30, 2026
pulisher
Apr 29, 2026

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.57% - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

XTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline - TipRanks

Apr 29, 2026
pulisher
Apr 29, 2026

XTL Biopharmaceuticals to acquire Psyga Bio for 40% stake - Investing.com

Apr 29, 2026
pulisher
Apr 28, 2026

Triangle DescendingStock ScreenerCharts - Finviz

Apr 28, 2026
pulisher
Apr 02, 2026

Top GainersStock ScreenerSnapshot - Finviz

Apr 02, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd ADR Each REPR 40 share price | XTLB - Hargreaves Lansdown

Apr 01, 2026
pulisher
Apr 01, 2026

Debt to assets ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Total assets of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Free cash flow per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

Tangible book value per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Apr 01, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Trade Ideas — SWB:HHB0 - TradingView

Apr 01, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Average basic shares outstanding of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

EBITDA margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LSX:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Return on assets % of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 27, 2026

Basic earnings per share (basic EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – LSX:A41X7J - TradingView — Track All Markets

Mar 27, 2026
pulisher
Mar 27, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – LS:A41X7J - TradingView

Mar 27, 2026
pulisher
Mar 26, 2026

Price to cash flow ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Revenue per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Statistics – GETTEX:A41X7J - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

XTL Biopharmaceuticals Ltd. Sponsored ADR Balance Sheet – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Diluted earnings per share (diluted EPS) of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Total operating expenses of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Gross margin % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Long term debt to total equity ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Price to sales ratio of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

Return on invested capital % of XTL Biopharmaceuticals Ltd. Sponsored ADR – MUN:HHB0 - TradingView

Mar 26, 2026

X T L Biopharmaceuticals Ltd Adr (XTLB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$117.83
price down icon 3.06%
$35.80
price down icon 0.91%
$58.21
price down icon 0.14%
$255.96
price up icon 2.55%
ONC ONC
$360.85
price up icon 0.24%
$204.97
price up icon 2.56%
大文字化:     |  ボリューム (24 時間):